Comparison of Viusal Outcomes After Implantation of the POD 26% FineVision Toric (PhysIOL) and POD 26% Toric (PhysIOL)

Sponsor
Beaver-Visitec International, Inc. (Industry)
Overall Status
Withdrawn
CT.gov ID
NCT02426385
Collaborator
(none)
0
6

Study Details

Study Description

Brief Summary

The study is an observational non-randomised controlled study comparing the visual acuity after implantation of the POD 26% FINEVISION TORIC with respect to the POD 26% TORIC

Condition or Disease Intervention/Treatment Phase
  • Device: FineVision Toric

Detailed Description

The study is an observational non-randomised controlled study comparing the visual acuity after implantation of the POD 26% FINEVISION TORIC with respect to the POD 26% TORIC This study includes both eyes of 24 patients implanted with the POD 26%FineVision Toric (group 1: 12 patients) and the POD 26% Toric (group 2: 12 patients) .

The study primary goal is to compare the near visual acuity in both groups. Distance and intermediate visual acuities, defocus curve, refraction and straylight will be compared.

Study Design

Study Type:
Observational
Actual Enrollment :
0 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Comparison of Viusal Outcomes After Implantation of the POD 26% FineVision
Actual Study Start Date :
Apr 1, 2015
Actual Primary Completion Date :
Oct 1, 2015
Actual Study Completion Date :
Oct 1, 2015

Arms and Interventions

Arm Intervention/Treatment
1POD26PFT

Patients implanted with the POD 26% FineVision Toric

Device: FineVision Toric
Posterior chamber IOL which consists in a small plastic lens with plastic side struts, called haptics, to hold the lens in place within the capsular bag inside the eye

2POD26PT

Patients implanted with the POD 26% Toric

Outcome Measures

Primary Outcome Measures

  1. The visual acuity at near of the POD 26% FINEVISION TORIC with respect to the POD 26% TORIC is improved of at least LogMAR 0.2. [3 months]

Secondary Outcome Measures

  1. The secondary objective is to measure far and intermediate visual acuity, the refraction, centration, rotational stability and to determine the amount of photic phenomena for both IOLs: POD 26% FINEVISION TORIC and POD 26% TORIC. [3 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
50 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Patient older than 50 years old

  • Regular corneal astigmatism >1.0 dioptres by IOL Master (regularity determined by the topography of the keratometry).

  • Regular corneal astigmatism <2.5 dioptres by IOL Master (regularity determined by the topography of the keratometry).

  • Group 1: patients after cataract surgery with Fine Vision toric implanted in both eyes

  • Group 2: patients after cataract surgery with Ankoris implanted in both eyes

  • Availability, willingness and sufficient cognitive awareness to comply with examination procedures

Exclusion Criteria:

• - Irregular astigmatism

  • Difficulty for cooperation (distance from their home, general health condition)

  • Acute or chronic disease or illness that would increase risk or confound study results (e.g. diabetes mellitus (with retinopathy), immunocompromised, glaucoma etc…)

  • Any ocular comorbidity

  • History of ocular trauma or prior ocular surgery including refractive procedures

  • Capsule or zonular abnormalities that may affect postoperative centration or tilt of the lens (e.g. pseudoexfoliation syndrome, chronic Uveitis, Marfan's syndrome)

  • Pupil abnormalitis (non-reactive, tonic pupils, abnormally shaped pupils or pupils that do not dilate under mesopic/scotopic conditions)

  • IOL spherical equivalent power lower than 10 D or greater than 30D

  • Complicated surgery

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Beaver-Visitec International, Inc.

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Beaver-Visitec International, Inc.
ClinicalTrials.gov Identifier:
NCT02426385
Other Study ID Numbers:
  • TaneriPODAYFT/PODAYT
First Posted:
Apr 24, 2015
Last Update Posted:
May 6, 2021
Last Verified:
May 1, 2021
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 6, 2021